NuMedii, Inc. have announced the formation of a research alliance with Allergan to explore new therapeutic options for the potential treatment of psoriasis. The companies will use NuMedii’s predictive Big

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In